Cetamid

Cetamid

acetazolamide

Manufacturer:

ACME

Distributor:

Sea King Pharma

Marketer:

Euro Generics
Concise Prescribing Info
Contents
Acetazolamide
Indications/Uses
Management of glaucoma, epilepsy, CHF & induced edema.
Dosage/Direction for Use
Chronic simple glaucoma 250 mg-1 g/24 hr in divided doses. Secondary glaucoma/pre-op treatment of some cases of acute congestive glaucoma 250 mg 4 hrly. In some acute cases, initially 500 mg then 125-250 mg 4 hrly. Epilepsy 8-30 mg/kg in divided doses. Max: 375-1,000 mg daily. CHF 250-375 mg once daily in the morning. Drug-induced edema 250-375 mg once daily for 1-2 days, alternating w/ a day of rest.
Administration
Should be taken with food.
Contraindications
Depressed Na &/or K blood serum levels, marked kidney or liver disease; suprarenal gland failure; hyperchloremic acidosis; cirrhosis. Long-term administration in chronic non-congestive angle closure glaucoma.
Special Precautions
Pulmonary obstruction or emphysema where alveolar ventilation may be impaired. Rapid ascent to high altitude. Pregnancy & lactation.
Adverse Reactions
Paresthesia, loss of appetite, hearing dysfunction or tinnitus, taste alteration, GI disturbances, polyuria, drowsiness & confusion, acidosis, transient myopia.
MIMS Class
Antiglaucoma Preparations / Diuretics
ATC Classification
S01EC01 - acetazolamide ; Belongs to the class of carbonic anhydrase inhibitors. Used in the treatment of glaucoma.
Presentation/Packing
Form
Cetamid tab 250 mg
Packing/Price
100's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in